Watch Ticker

Traws Pharma, Inc. Common Stock

Go to Traws Pharma, Inc. Common Stock Website

$1.53

0.00 (0.00%)

Live

Previous Close

$1.53

Day Range

$0 - $0

Previous Day Range

$1.48 - $1.55

Market Cap

$8.5 million USD

Day Vol.

Previous Day Vol.

13353

Currency

USD

Primary Exchange

None

Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent a...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

N/A - Traws Pharma Announces Publication of Compelling Efficacy data in RDEB SCC Patients Treated with Legacy Oncology Drug Rigosertib

Traws Pharma announces the publication of positive clinical data for its legacy oncology drug rigosertib in treating recessive dystrophic epidermolysis bullosa-associated squamous cell carcinoma (RDEB SCC), a rare and aggressive form of skin cancer.

Related tickers: TRAW.

Read Full Article

Traws Pharma, Inc. - Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update

Traws Pharma Reports First Quarter 2024 Financial Results and Provides Business Update

Related tickers: TRAW.

Read Full Article

Trending Tickers

Please sign in to view